Local Innovative Pharmaceutical Companies: Will the Intersection of Capital Welcomes the Next 'Golden Decade'?

By 2025, the global pharmaceutical sector has been increasingly focused on China's innovative pharmaceutical companies. With robust domestic policies supporting R&D of innovative drugs and breakthroughs in major disease areas like cancer, the environment for these companies has become highly favorable, attracting significant talent and capital influx. The internationally recognized efficacy and safety of China's innovative drugs have sparked growing interest and demand in overseas markets, leading to numerous international pharmaceutical companies seeking collaboration. Data from the National Medical Products Administration revealed a 59% increase in approvals for innovative drugs in the first half of the year compared to the…